Abstract
With the explosion of protein sequences generated in the postgenomic era, the gap between the number of attribute- known proteins and that of uncharacterized ones has become increasingly large. Knowing the key attributes of proteins is a shortcut for prioritizing drug targets and developing novel new drugs. Unfortunately, it is both time-consuming and costly to acquire these kinds of information by purely conducting biological experiments. Therefore, it is highly desired to develop various computational tools for fast and effectively classifying proteins according to their sequence information alone. The process of developing these high throughput tools is generally involved with the following procedures: (1) constructing benchmark datasets; (2) representing a protein sequence with a discrete numerical model; (3) developing or introducing a powerful algorithm or machine learning operator to conduct the prediction; (4) estimating the anticipated accuracy with a proper and objective test method; and (5) establishing a user-friendly web-server accessible to the public. This minireview is focused on the recent progresses in identifying the types of G-protein coupled receptors (GPCRs), subcellular localization of proteins, DNA-binding proteins and their binding sites. All these identification tools may provide very useful informations for in-depth study of drug metabolism.
Keywords: GPCR type, protein subcellular localization, DNA-binding protein, discrete model, PseAAC, protein attribute predictor, web-servers.
Current Topics in Medicinal Chemistry
Title:Recent Advances in Predicting Protein Classification and Their Applications to Drug Development
Volume: 13 Issue: 14
Author(s): Xuan Xiao, Wei-Zhong Lin and Kuo-Chen Chou
Affiliation:
Keywords: GPCR type, protein subcellular localization, DNA-binding protein, discrete model, PseAAC, protein attribute predictor, web-servers.
Abstract: With the explosion of protein sequences generated in the postgenomic era, the gap between the number of attribute- known proteins and that of uncharacterized ones has become increasingly large. Knowing the key attributes of proteins is a shortcut for prioritizing drug targets and developing novel new drugs. Unfortunately, it is both time-consuming and costly to acquire these kinds of information by purely conducting biological experiments. Therefore, it is highly desired to develop various computational tools for fast and effectively classifying proteins according to their sequence information alone. The process of developing these high throughput tools is generally involved with the following procedures: (1) constructing benchmark datasets; (2) representing a protein sequence with a discrete numerical model; (3) developing or introducing a powerful algorithm or machine learning operator to conduct the prediction; (4) estimating the anticipated accuracy with a proper and objective test method; and (5) establishing a user-friendly web-server accessible to the public. This minireview is focused on the recent progresses in identifying the types of G-protein coupled receptors (GPCRs), subcellular localization of proteins, DNA-binding proteins and their binding sites. All these identification tools may provide very useful informations for in-depth study of drug metabolism.
Export Options
About this article
Cite this article as:
Xiao Xuan, Lin Wei-Zhong and Chou Kuo-Chen, Recent Advances in Predicting Protein Classification and Their Applications to Drug Development, Current Topics in Medicinal Chemistry 2013; 13 (14) . https://dx.doi.org/10.2174/15680266113139990113
DOI https://dx.doi.org/10.2174/15680266113139990113 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
Reviews on Recent Clinical Trials Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings
Current Radiopharmaceuticals Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Current Cancer Drug Targets Cetuximab: Its Use in Combination with Radiation Therapy and Chemotherapy in the Multimodality Treatment of Head and Neck Cancer
Recent Patents on Anti-Cancer Drug Discovery Neuropeptides as Autocrine Growth Factors in Cancer Cells
Current Pharmaceutical Design Large-Scale Prediction of Drug Targets Based on Local and Global Consistency of Chemical-Chemical Networks
Combinatorial Chemistry & High Throughput Screening Effects of Liver Diseases on Drug-metabolizing Enzymes: Implications for Drug Fate Alterations and Nano-therapeutic Openings
Current Medicinal Chemistry ADAM10 as a Therapeutic Target for Cancer and Inflammation
Current Pharmaceutical Design Evaluation of Antidiabetic Activity of <i>Rosmarinus officinalis var. prostratus</i> Growing in Syria in Alloxan Diabetic Rats
Current Bioactive Compounds Crocetin: an Agent Derived from Saffron for Prevention and Therapy for Cancer
Current Pharmaceutical Biotechnology Bergamot Juice Extract Inhibits Proliferation by Inducing Apoptosis in Human Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Ubiquitin Carboxyl Hydrolase L1 Significance for Human Diseases
Protein & Peptide Letters A Wnt-ow of Opportunity: Targeting the Wnt/β-Catenin Pathway in Breast Cancer
Current Drug Targets Advances in Clinical Study of Curcumin
Current Pharmaceutical Design Aberrant DNA Methylation and Prostate Cancer
Current Genomics Non Steroidal Anti Inflammatory Drugs As Gatekeepers Of Colon Carcinoma Highlight New Scenarios Beyond Cyclooxygenases Inhibition
Current Cancer Drug Targets The Significance of Meat in the Diet
Current Nutrition & Food Science Polymeric Nanoparticles of Aromatase Inhibitors: A Comprehensive Review
Current Pharmaceutical Design New Perspective on the Dual Functions of Indirubins in Cancer Therapy and Neuroprotection
Anti-Cancer Agents in Medicinal Chemistry DNA Mismatch Repair Deficiency, Resistance to Cancer Chemotherapy and the Development of Hypersensitive Agents
Current Topics in Medicinal Chemistry